ALGS
Aligos Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.57
+0.16 ▲ +2.16%
🌙 3월 13일 7:12 PM ET (한국 3/14 08:12)
$7.40
-0.17 ▼ -2.25%
| Index | - | P/E | - | EPS (ttm) | -8.6 | Insider Own | 21.96% | Shs Outstand | 0.01B | Perf Week | 8.45% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | 23.13% | Insider Trans | - | Shs Float | 0.00B | Perf Month | 1.47% |
| Enterprise Value | -0.03B | PEG | - | EPS next Q | -2.24 | Inst Own | 45.68% | Short Float | 6.04% | Perf Quarter | -33.19% |
| Income | -0.02B | P/S | 21.39 | EPS this Y | -166.6% | Inst Trans | 2.65% | Short Ratio | 4.83 | Perf Half Y | -30.42% |
| Sales | 0.00B | P/B | 0.87 | EPS next 5Y | 27.67% | ROA | -29.97% | Short Interest | 0.29M | Perf YTD | -18.78% |
| Book/sh | 8.67 | P/C | 0.6 | EPS past 3/5Y | - | ROE | -196.92% | 52W High | -44.7% ($13.69) | Perf Year | -26.36% |
| Cash/sh | 12.6 | P/FCF | - | Sales past 3/5Y | -46.03% - | ROIC | -43.93% | 52W Low | 101.33% ($3.76) | Perf 3Y | -76.71% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 93.48% | Gross Margin | 57.46% | Volatility(W/M) | 7.72% 8.51% | Perf 5Y | -98.84% |
| Dividend TTM | - | EV/Sales | -11.81 | Sales Y/Y TTM | -44.59% | Oper. Margin | -4024.93% | ATR (14) | 0.64 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.9 | EPS Q/Q | 85.36% | Profit Margin | -1106.72% | RSI (14) | 53.98 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.9 | Sales Q/Q | -73.13% | SMA20 | 7.53% ($7.04) | Beta | 2.69 | Target Price | $70.25 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 3000000 | SMA50 | -2.37% ($7.75) | Rel Volume | 0.68 | Prev Close | $7.41 |
| Employees | 82 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 23.19% -61.59% | SMA200 | -12.42% ($8.64) | Avg Volume(3M) | 0.06M | Price | $7.57 |
| IPO | 2020/10/16 | Option/Short | No/Yes | Trades | 1165 | Volume | 40,680 | Change | 2.16% |
뉴스 로딩 중...